• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

reneuron - Articles and news items

First patient treated in trial of ReNeuron’s retinitis pigmentosa cell therapy

Industry news / 15 March 2016 / Victoria White

ReNeuron has demonstrated that its Human Retinal Progenitor Cells (hRPCs) improve visual acuity in preclinical models of retinal degeneration…

FDA grants Fast Track designation to ReNeuron’s retinitis pigmentosa cell therapy candidate

Industry news / 22 May 2015 / Victoria White

The FDA has granted Fast Track designation to ReNeuron’s human Retinal Progenitor Cell (hRPC) therapy candidate for retinitis pigmentosa…

ReNeuron provides more data from Phase I trial of CTX stem cell therapy for stroke patients

Industry news / 21 April 2015 / Victoria White

ReNeuron has provided a further and final update on the PISCES Phase I clinical trial of its CTX stem cell therapy for disabled stroke patients…

ReNeuron

ReNeuron files application to commence Phase I/II clinical trial with its stem cell therapy candidate for retinitis pigmentosa

Industry news / 13 April 2015 / Victoria White

ReNeuron has announced that it has filed an IND application with the FDA to commence a Phase I/II clinical trial with its hRPC therapy candidate for RP…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +